Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

ASK NEWS:
  • The Best Dividend-Paying Healthcare Stocks - Motley Fool
    ... reach $10.33 in 2016. Bristol-Myers ... the sale of its diabetes business ... the top-selling cancer drug Yervoy ... but only if the ...
    03/29/2015 - 1:21 pm | View Link
  • Out of 12 Big Pharma Stocks, This is the 1 You Can Confidently Hold ... - Motley Fool
    Merck and Bristol-Myers are working with other drug hopefuls, one drug ... is good news since diabetes and ... this sector you can confidently ...
    03/28/2015 - 2:15 pm | View Link
  • More
BING NEWS:
  • I Think This Next-Generation Diabetes Drug Offers the Greatest Growth Potential
    The number of people diagnosed with diabetes globally ... The start-up also has a second drug PRL002 that Perle believes is more potent than PRL001, which could be in the clinic in 2016. Unfortunately, you can't currently buy shares in the company, because ...
    01/10/2015 - 3:48 am | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    The move will bulk up AstraZeneca's thin drug portfolio and give Bristol ... Speculation that AstraZeneca might look to buy out Bristol was fuelled last month when the U.S.-based company decided to get out of diabetes research. The decision to quit ...
    12/18/2013 - 7:07 pm | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    Speculation that AstraZeneca might look to buy out Bristol was fuelled last month when ... received a boost when an advisory panel to the U.S. Food and Drug Administration endorsed its new diabetes pill dapagliflozin.
    12/18/2013 - 7:04 pm | View Link
  • AstraZeneca could buy Bristol stake in diabetes JV: analyst
    AstraZeneca may seek to increase its stake in a diabetes joint venture with Bristol-Myers Squibb, following a decision by the U.S. firm to exit diabetes drug research, according to Citi. Bristol said on Thursday it would no longer conduct research to ...
    11/8/2013 - 5:38 am | View Link
  • Bristol-Myers to buy diabetes drug maker for $5B
    (AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers says it will pay $31 per share for Amylin in a cash tender offer. Including Amylin's debt and a ...
    07/1/2012 - 6:42 am | View Link
  • More
BING SEARCH:
  • Diabetes Wiki
    Diabetes Wiki is a community site that anyone can contribute to. Discover, share and add your knowledge!
    04/27/2015 - 3:47 pm | View Website
  • Prednisone Disease Interactions
    Comprehensive disease interaction information for prednisone. Includes Corticosteroids - (+) Tuberculin Test.
    04/27/2015 - 11:08 am | View Website
  • American Diabetes AssociationĀ®
    Their mission is to prevent and cure diabetes and to improve the lives of all people affected by this disease. [English and Spanish]
    04/26/2015 - 11:12 pm | View Website
  • Adult Type 2 Diabetes Medication | Onglyza.com
    Read information about ONGLYZA® (saxagliptin), an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.
    04/26/2015 - 6:26 pm | View Website
  • Dr. Neal Barnard's Program for Reversing Diabetes: The ...
    Dr. Neal Barnard's Program for Reversing Diabetes: The Scientifically Proven System for Reversing Diabetes Without Drugs MP3 CD – Audiobook, MP3 Audio, Unabridged
    04/26/2015 - 5:28 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News